Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Current status and future opportunities for controlling acromegaly.
Melmed S, Vance ML, Barkan AL, Bengtsson BA, Kleinberg D, Klibanski A, Trainer PJ. Melmed S, et al. Among authors: barkan al. Pituitary. 2002;5(3):185-96. doi: 10.1023/a:1023369317275. Pituitary. 2002. PMID: 12812311 Free article. Review.
Acromegaly. Diagnosis and therapy.
Barkan AL. Barkan AL. Endocrinol Metab Clin North Am. 1989 Jun;18(2):277-310. Endocrinol Metab Clin North Am. 1989. PMID: 2663476 Review.
Acromegaly. Recognition and treatment.
Jaffe CA, Barkan AL. Jaffe CA, et al. Among authors: barkan al. Drugs. 1994 Mar;47(3):425-45. doi: 10.2165/00003495-199447030-00004. Drugs. 1994. PMID: 7514973 Review.
Octreotide as primary therapy for acromegaly.
Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL. Newman CB, et al. J Clin Endocrinol Metab. 1998 Sep;83(9):3034-40. doi: 10.1210/jcem.83.9.5109. J Clin Endocrinol Metab. 1998. PMID: 9745397 Clinical Trial.
Criteria for cure of acromegaly: a consensus statement.
Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S. Giustina A, et al. J Clin Endocrinol Metab. 2000 Feb;85(2):526-9. doi: 10.1210/jcem.85.2.6363. J Clin Endocrinol Metab. 2000. PMID: 10690849 Review.
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ. Trainer PJ, et al. Among authors: barkan al. N Engl J Med. 2000 Apr 20;342(16):1171-7. doi: 10.1056/NEJM200004203421604. N Engl J Med. 2000. PMID: 10770982 Free article. Clinical Trial.
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist.
van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO. van der Lely AJ, et al. Among authors: barkan al. Lancet. 2001 Nov 24;358(9295):1754-9. doi: 10.1016/s0140-6736(01)06844-1. Lancet. 2001. PMID: 11734231 Clinical Trial.
204 results